Moreover, even though our results were obtained from a very select cohort of patients, our findings are also confirmed by the recent literature [10,17], indicating that the MLH1 epigenetic mechanism could be involved in LS carcinogenesis as a second hit. Here, MLH1 is linked to Leigh syndrome.